In the News

400 News Items found
Breast cancer patient LaDawn Jefferson poses outside with her running medals
Living With Stage 4 Cancer
For those living with advanced cancer, quality of life means pursuing what matters most to each person — whether that’s making art, running marathons, caring for others, or spending more time with family.
Scientific image showing spindle-shaped and round dormant metastatic cancer cells
New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.
DNA molecules wrapped around histones
Feature
Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Dr. Sohrab Shah
MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research.
Medical oncologist Emily Feld
Q&A
In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.
MSK radiation oncologist Kathryn Beal
In the Clinic
MSK’s Kathryn Beal presents new findings on combining radiation with immunotherapy for brain cancer.
Dr. Alison Schram
The FDA has approved zenocutuzumab (Bizengri®) for adults with advanced, unresectable, or metastatic cholangiocarcinoma driven by a molecular change called an NRG1 gene fusion, based on a trial led by an MSK investigator.
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
bowl of edamame
Learn whether eating soy products causes cancer.
Sir Murray Brennan and Bob Li wearing white coats and posing for a photo outside
Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.